1. A blood draw is taken from the mother
2. The sample is sequenced – fetal and maternal DNAs are still mixed
3. Fetus’s DNA is digitally isolated using Identifai’s computational process
The challenge
10% disorders detected today
Undetected
Solution
1
2
3
Technology
Identifai’s cutting edge bioinformatics technology offers an early and comprehensive prenatal screening test for genetic syndromes. Using a simple blood test from the mother during the first trimester of the pregnancy, our proprietary data science algorithms provide a high-resolution yet comprehensive perspective of the fetus’s health at an early stage of the pregnancy.
1. A blood draw is taken from the mother
Current solutions
Current technologies are either invasive, e.g. amniotic fluid test, or limited to only ~10% of genetic conditions, mainly chromosomal abnormalities.
Detect chromosomal conditions
Our solution
Identifai’s technology offers the only available clinical solution for an early, non-invasive and comprehensive prenatal genetic screening, from point mutations to chromosomal anomalies.
Coverage
Resolution
News & Publications
About Us
Collaborators
Contact Us
© All rights reserved idefntifAI LTD 2022 | Developed and Managed by Web Engine